Fresh analysis indicates that individuals who come off new weight-loss injections like Wegovy and Mounjaro may regain reduced body mass far faster than those who end conventional lifestyle plans.
Research printed in a leading health publication shows that while overweight individuals frequently drop substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month once they quit.
"Users purchasing such drugs need to be aware of the danger of rapid weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
This pace of recovery implies a return to original mass in about one and a half years.
Weighing Therapies
The research, which looked at dozens of studies involving thousands of patients, compared the effects of the injectable medications with other pills.
Scientists emphasize that individuals who shed pounds through diet and exercise typically experience a more gradual weight regain—around 0.1 kg a month—after stopping.
Explaining the Fast Regain
Doctors propose the way of the jabs accounts for the heightened weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating a significant risk."
An Ongoing Disease?
Health authorities suggest the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts contend that, considering the significant potential of weight regain, the therapy might need to be life-long.
This opinion is supported by pharmaceutical companies, who say that the results "emphasize the persistent nature of excess weight," comparing it to managing diseases like hypertension.
Patient Experiences
Users who have come off the jabs describe a powerful resurgence of hunger.
"I experienced something activating and I was suddenly ravenous," said a patient.
This difficulty is exacerbated if patients have not developed sustainable lifestyle or habit modifications during therapy.
Growing Interest
Figures indicate that a significant number of adults in the UK have used these injections in the past year, with desire remaining high.
- Use is more common among females compared to males.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, clinicians caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent cure and long-term success likely depends on integrated behavioural support.
